Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients ...

Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond ...

A new brain-imaging study has revealed how ketamine produces its fast antidepressant effects in people with treatment-resistant depression. Researchers tracked changes in a critical brain receptor ...

Researchers used a novel PET tracer to visualize how ketamine alters AMPA receptor distribution in the brains of patients ...

Major depressive disorder (MDD) is a major global health problem and one of the leading causes of disability. About 30% of people diagnosed with ...

A recent study published in Physiology & Behavior suggests that administering ketamine during periods of social stress in adolescence can prevent the development of anxiety and social withdrawal.

Carly Schwartz hid her severe depression while working in Big Tech. Here's how she fought her way through and learned to be honest with colleagues.

Taking psilocybin – the psychedelic component of magic mushrooms – eased symptoms of obsessive compulsive disorder among ...